A comprehensive analysis was conducted using the TCGA, CGGA and GEO databases, covering the expression level of ITPRIPL1 in glioma, clinical characteristics, prognostic value, immunological value, targeted drug screening, and biological functions. This evidence concerns the gene ITPRIPL1 and glioma.